Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species

PLoS Neglected Tropical Diseases

Volumn 6, Issue 4, 2012, Pages

  Rodriguez Pinto, Daniel ^a   Navas, Adriana ^a   Blanco, Víctor Manuel ^a   Ramírez, Lady ^a   Garcerant, Daniel ^a   Cruz, Adriana ^a   Craft, Noah ^b   Saravia, Nancy Gore ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDOLEAMINE 2, 3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 7 RECEPTOR; MEGLUMINE ANTIMONATE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; TNFRSF18 PROTEIN, HUMAN;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEALING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; LEISHMANIA; LEISHMANIA VIANNIA; LEISHMANIN SKIN TEST; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN LEISHMANIASIS; ASYMPTOMATIC DISEASE; BIOSYNTHESIS; CHEMISTRY; CHRONIC DISEASE; FEMALE; GENE EXPRESSION PROFILING; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; PATHOLOGY; SKIN;

ANTIGENS, CD4; ASYMPTOMATIC DISEASES; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; SKIN; T-LYMPHOCYTES, REGULATORY;

EID: 84861217458     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001627     Document Type: Article

References (64)

1. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. Lancet 366: 1561-1577.
2. Saravia NG, Valderrama L, Labrada M, Holguín AF, Navas C, et al. (1989) The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 159: 725-735.
3. Carvalho EM, Johnson WD, Barreto E, Marsden PD, Costa JL, et al. (1985) Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 135: 4144-4148.
4. Castilho TM, Goldsmith-Pestana K, Lozano C, Valderrama L, Saravia NG, et al. (2010) Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease. Eur J Immunol 40: 2816-2829.
5. Díaz YR, Rojas R, Valderrama L, Saravia NG, (2010) T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species. J Infect Dis 202: 406-415.
6. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição-Silva F, et al. (1993) Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91: 1390-1395.
7. Belkaid Y, Tarbell K, (2009) Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol 27: 551-589.
8. Sanchez AM, Yang Y, (2010) The role of natural regulatory T cells in infection. Immunol Res 49: 124-134.
9. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
10. Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y, (2004) Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 200: 201-210.
11. Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA, et al. (2002) The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J Immunol 169: 3232-3241.
12. Xu D, Liu H, Komai-Koma M, Campbell C, McSharry C, et al. (2003) CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 170: 394-399.
13. Ji J, Masterson J, Sun J, Soong L, (2005) CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 174: 7147-7153.
14. Salhi A, Rodrigues V Jr, Santoro F, Dessein H, Romano A, et al. (2008) Immunological and genetic evidence for a crucial role of IL-10 in dermal lesions in humans infected with Leishmania braziliensis. J Immunol 180: 6139-6148.
15. Campanelli AP, Roselino AM, Cavassani KA, Pereira MS, Mortara RA, et al. (2006) CD4+CD25+ T cells in skin lesions of patients with dermal leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193: 1313-1322.
16. Bourreau E, Ronet C, Darcissac E, Lise MC, Sainte Marie D, et al. (2009) Intralesional regulatory T-cell suppressive function during human acute and chronic dermal leishmaniasis due to Leishmania guyanensis. Infect Immun 77: 1465-1474.
17. Bourreau E, Ronet C, Darsissac E, Lise MC, Marie DS, et al. (2009) In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment. J Infect Dis 199: 576-579.
18. Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, et al. (1990) Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection? Lancet 336: 398-402.
19. Wortmann GW, Aronson NE, Miller RS, Blazes D, Oster CN, (2000) Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 31: 199-201.
20. de Oliveira Camera P, Junger J, do Espírito Santo Silva Pires F, Mattos M, Oliveira-Neto MP, et al. (2006) Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis. Trans R Soc Trop Med Hyg 100: 1112-1117.
21. Vergel C, Palacios R, Cadena H, Posso CJ, Valderrama L, et al. (2006) Evidence for leishmania (viannia) parasites in the skin and blood of patients before and after treatment. J Infect Dis 194: 503-511.
22. Schubach A, Haddad F, Oliveira-Neto MP, Degrave W, Pirmez C, et al. (1998) Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 178: 911-914.
23. Schubach A, Marzochi MC, Cuzzi-Maya T, Oliveira AV, Araujo ML, et al. (1998) Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hyg 58: 824-827.
24. Corredor A, Kreutzer RD, Tesh RB, Boshell J, Palau MT, et al. (1990) Distribution and etiology of leishmaniasis in Colombia. Am J Trop Med Hyg 42: 206-214.
25. Osorio LE, Castillo CM, Ochoa MT, (1998) Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics. Am J Trop Med Hyg 59: 49-52.
26. Guarín N, Palma GI, Pirmez C, Valderrama L, Tovar R, et al. (2006) Comparative immunohistological analysis of the Montenegro skin test reaction in asymptomatic infection and in acute and chronic dermal leishmaniasis. Biomedica 26: 38-48.
27. Saravia NG, Weigle K, Navas C, Segura I, Valderrama L, et al. (2002) Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia. Am J Trop Med Hyg 66: 738-744.
28. Bosque F, Saravia NG, Valderrama L, Milon G, (2000) Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol 51: 533-541.
29. Brusko TM, Hulme MA, Myhr CB, Haller MJ, Atkinson MA, (2007) Assessing the in vitro suppressive capacity of regulatory T cells. Immunol Invest 36: 607-628.
30. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
31. Baecher-Allan C, Viglietta V, Hafler DA, (2004) Human CD4+CD25+ regulatory T cells. Semin Immunol 16: 89-98.
32. Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E, (2002) Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 106: 190-199.
33. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA, (2003) CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found Symp 252: 67-91.
34. Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, et al. (2002) Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 196: 1335-1346.
35. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
36. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, et al. (2004) Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16: 1643-1656.
37. Miyara M, Sakaguchi S, (2011) Human Foxp3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 89: 346-351.
38. Grohmann U, Fallarino F, Puccetti P, (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24: 242-248.
39. Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774.
40. Taylor MW, Feng GS, (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5: 2516-2522.
41. Hassanain HH, Chon SY, Gupta SL, (1993) Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and-alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor. J Biol Chem 268: 5077-5084.
42. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, et al. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4: 1206-1212.
43. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, et al. (2005) The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 174: 3143-3147.
44. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A, (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
45. Walther M, Tongren JE, Andrews L, Korbel D, King E, et al. (2005) Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
46. Lin CY, Tsai MC, Huang CT, Hsu CW, Tseng SC, et al. (2007) Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B. J Viral Hepat 14: 503-511.
47. Souza-Lemos C, de-Campos SN, Teva A, Porrozzi R, Grimaldi G Jr, (2011) In situ characterization of the granulomatous immune response with time in nonhealing lesional skin of Leishmania braziliensis-infected rhesus macaques (Macaca mulatta). Vet Immunol Immunopathol 142: 147-155.
48. Katara GK, Ansari NA, Verma S, Ramesh V, Salotra P, (2011) Foxp3 and IL-10 Expression Correlates with Parasite Burden in Lesional Tissues of Post Kala Azar Dermal Leishmaniasis (PKDL) Patients. PLoS Negl Trop Dis 5: e1171.
49. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE, Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007 Jan;37 (1): 129-38.
50. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK, Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007 Apr;19 (4): 345-54.
51. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the Foxp3 transcription factor. Immunity 30: 899-911.
52. Bluestone JA, Abbas AK, (2003) Natural versus adaptive regulatory T cells. Nat Rev Immunol 3: 253-257.
53. Wohlfert E, Belkaid Y, (2008) Role of endogenous and induced regulatory T cells during infections. J Clin Immunol 28: 707-715.
54. Kautz-Neu K, Noordegraaf M, Dinges S, Bennett CL, John D, et al. (2011) Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 208: 885-891.
55. Dudda JC, Perdue N, Bachtanian E, Campbell DJ, (2008) Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med 205: 1559-1565.
56. Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, et al. (2005) Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104.
57. Crome SQ, Clive B, Wang AY, Kang CY, Chow V, et al. (2010) Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J Immunol 185: 3199-3208.
58. Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, et al. (2009) Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729.
59. Bollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, et al. (2009) Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 86: 567-572.
60. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, et al. (2002) Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 196: 255-260.
61. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA, (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167: 1245-1253.
62. Anderson CF, Oukka M, Kuchroo VJ, Sacks D, (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic dermal leishmaniasis. J Exp Med 204: 285-297.
63. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
64. O'Garra A, Vieira P, (2007) T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7: 425-428.